TY - JOUR
T1 - Albinism
AU - Oetting, William S.
PY - 1999/12/4
Y1 - 1999/12/4
N2 - Albinism was one of the first genetic diseases to be noted in humans, but until relatively recently, little was known of the molecular mechanisms involved in its pathogenesis. Recent advances have shown us that mutations in at least seven different genes can cause a reduction in melanin pigment biosynthesis, producing the various associated clinical features associated with albinism, including hypopigmentation of the skin, hair, and eyes; optic track misrouting; foveal hypoplasia; and reduced visual acuity. Analysis of mutations in these seven genes has revealed that the phenotypic spectrum associated with albinism is broad, making molecular analysis an important part in the accurate diagnosis of this disease.
AB - Albinism was one of the first genetic diseases to be noted in humans, but until relatively recently, little was known of the molecular mechanisms involved in its pathogenesis. Recent advances have shown us that mutations in at least seven different genes can cause a reduction in melanin pigment biosynthesis, producing the various associated clinical features associated with albinism, including hypopigmentation of the skin, hair, and eyes; optic track misrouting; foveal hypoplasia; and reduced visual acuity. Analysis of mutations in these seven genes has revealed that the phenotypic spectrum associated with albinism is broad, making molecular analysis an important part in the accurate diagnosis of this disease.
UR - http://www.scopus.com/inward/record.url?scp=0032754928&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032754928&partnerID=8YFLogxK
U2 - 10.1097/00008480-199912000-00016
DO - 10.1097/00008480-199912000-00016
M3 - Article
C2 - 10590917
AN - SCOPUS:0032754928
SN - 1040-8703
VL - 11
SP - 565
EP - 571
JO - Current Opinion in Pediatrics
JF - Current Opinion in Pediatrics
IS - 6
ER -